The story of Viagra, and its parent company copyright, presents a complex case study for investors. At first a blockbuster drug, yielding billions in revenue , its patent expiration created a wave of lower-priced alternatives , significantly impacting its market share . While certain firms may seek to capitalize on related treatments , the current